PAN Foundation Celebrates its Commitment to Hepatitis C Patients
Washington, D.C., December 9, 2013 – As new therapies for Hepatitis C enter the market, the Patient Access Network (PAN) Foundation is pleased to extend its commitment to providing co-pay assistance to the underinsured patients who will be seeking these treatments. PAN’s unwavering dedication to removing the cost burden of novel therapies will give HCV patients better access to potentially life-saving medications as soon as treatments become available.
“The world of Hepatitis C treatment is changing dramatically,” said Dr. Patrick McKercher, PAN President. “Until recently treatment side effects have been a major obstacle to improved cure rates, therefore it is exciting to see side-effects reduced as well as more effective and convenient regimens. Patients are instilled with a new hope for returning to healthy and productive lives. The PAN Foundation aims to ensure that patients are able to access the therapy that is best suited to their disease and to their lifestyle, without wondering how they will afford the out-of-pocket costs associated with these new therapies.”
Qualifying patients receive initial grants to cover up to $7,000 for cost-sharing obligations associated with their medications. Patients must have insurance that covers a part of their treatment, must have a household income less than or equal to 500% of the Federal Poverty Level and must reside and receive treatment in the United States.
About the PAN Foundation
Patient Access Network Foundation is dedicated to providing help and hope to patients who would otherwise be unable to afford high-cost specialty medications. PAN envisions a society in which every individual can access needed medical care, offering hope for a healthy tomorrow. PAN provides assistance through more than 50 disease-specific programs designed to help patients being treated for certain cancers, chronic illnesses, and rare diseases. Through our streamlined application process and state of the art online tools, we are able to ensure that patients are put on the fast track to therapy.